week 3 semaglutide no weight loss versus placebo in individuals with poor after bariatric surgery: a double-blinded, randomized, placebo-controlled trial Semaglutide, also known as Ozempic,

Following RYGB, the GLP-1 concentrations in postprandial plasma were markedly increased (Laferrere et al., 2007)

To better understand the delivery science behind this, see our All About Liposomes page

Lifestyle changes, such as a balanced diet and increased physical activity, are typically recommended in conjunction with Semaglutide for weight management to maximize results

If taste changes significantly impair nutrition or quality of life despite management strategies, your healthcare provider may consider dose reduction, temporary treatment interruption, or switching to an alternative medication

Work by Culhane et al